New York's Eyenovia Preps for $30M IPO

Xconomy New York —Eyenovia, a startup that has adapted an inkjet printing technique into a way to deliver drugs to the eye, is providing more clarity on an initial public offering intended to finance late-stage clinical testing of its technology.

New York-based Eyenovia plans to offer 2.73 million shares priced between $10 and $12 each, according to an updated prospectus filed with securities regulators. At the midpoint, the IPO would raise $30 million. The company has applied for a listing on the Nasdaq exchange under the stock symbol “EYEN.”